News > Latest News

Walk News | Sponsor & Foundation News | News in the Parkinson's Disease Community

Walk News

Click on a headline to read the latest about Parkinson's Unity Walk. 


The 22nd Parkinsonís Unity Walk Raised More Than $1.4 Million for Parkinsonís Research

Top 50 Teams - Parkinson's Unity Walk 2016

Muhammad Ali, Truly the "Greatest"

Favorite Walk Moments from the 2016 Parkinson's Unity Walk

Team Photos from the 22nd Parkinson's Unity Walk

Submit Your Favorite Walk Moments from the 22nd Unity Walk

Attendees at the 22nd Parkinsonís Unity Walk Will Find Valuable New Resources for Managing Symptoms of Parkinsonís Disease

The 22nd Parkinsonís Unity Walk to Take Place on Saturday, April 23rd in New York Cityís Central Park

Winner of Register Early Incentive Announced

Rock Steady Boxing is the Recipient of the 2016 Alan Bonander Humanitarian Award

Register Early for a Chance to Win a Visa Gift Card

Meet Rafael Colon, Artist and Champion in the Fight Against Parkinsonís Disease

Fall 2015 Newsletter

Your Dollars at Work Ė 2015 PUW Research Grants Have Been Awarded

PUW Memory Quilt Winner Presents Prize to Dr. Di Rocco at NYU Langone Medical Center

Top 50 Teams - Parkinson's Unity Walk 2015

The 21st Parkinsonís Unity Walk Raised More Than $1.7 Million Dollars for Parkinsonís Research

Video of Favorite Moments from the 21st Parkinson's Unity Walk

Poem by Maryum "May May" Ali Read at the 21st Parkinson's Unity Walk

Every Step Counts at the 21st Parkinsonís Unity Walk on April 25th at Central Park in New York City

Congratulations to the Winner of the Hotel Gift Card

back to top

Sponsor & Foundation News

The Michael J. Fox Foundation Expands Fox Trial Finder to Accelerate Research in Atypical Parkinsonism

Michael J. Fox Foundation for Parkinsonís Research and Parkinsonís Action Network Announce Plans for Integration

Survey Examines Patient Perceptions of Nutrition and Diet in Managing the Symptoms of Parkinsonís Disease

APDA Establishes Research Fund in Memory of Joel Gerstel

Dementia Drug May Improve Gait in Parkinson's Patients

Acorda Therapeutics to Acquire Biotie Therapies

Participants Invited to Take Survey on Cognition and Parkinsonís Disease

Adamas Announces Positive Phase 3 Results for Treatment of Levodopa-induced Dyskinesia in Patients With PD

UCB Trials Wearable Sensor for Parkinson's Disease

Biogen Enters Collaboration with the Parkinsonís Institute and Clinical Center

Parkinsonís Institute and Clinical Center Publishes a Review on the State of Parkinsonís Research in Nature Genetics

Acorda Therapeutics Supports the National Disability Instituteís Financial Wellness Webinar Series

Podcast Focusing on Cultivating Patience for Well Being in Parkinson's Disease

The Parkinson Alliance Survey Reports a Relationship Between Patience and Well-Being in Parkinsonís Disease

NPFís Medical Director Publishes New Book on Breakthrough Therapies for PD

INTREPID Clinical Trial for DBS Continues Recruitment

Participants Invited to Take Survey on Nutrition and Parkinsonís Disease

The Michael J. Fox Foundation and Imago Pharmaceuticals Partner to Speed Parkinson's Research

Adamas Pharmaceuticals Issued Patent

Participants Invited to Take Survey on Patience and Well-Being in Parkinsonís Disease

back to top

News in the Parkinson's Disease Community

Study Shows Cancer Drug Raises Dopamine Levels in Parkinsonís Patients

Parkinson's Disease Biomarker Found in Patient Urine Samples

Johns Hopkins Researchers Reveal Novel Protein and Involvement in Parkinsonís Disease

Scientists Offer New View on Origins of Parkinson's Disease

NeuroDerm Presents Three Posters at the 20th International Congress of Parkinsonís Disease and Movement Disorders

MS Drug Could Prove Effective Parkinson's Treatment

UCLA Scientists Discover Protective Strategy Against Pesticide-linked Parkinsonís Disease

New Gene Shown to Cause Parkinson's Disease

Great Lakes Neurotech Validation Studies on Wearable Tech for Parkinsonís to be Highlighted at International Conference

NeuroDerm Announces Patient Enrollment in Long-Term Safety Trial of ND0612 for PD

U.S. Approves First drug for Psychosis Linked to Parkinson's Disease

Adamas Pharma (ADMS) Announces ADS-5102 Phase 3 Met Primary, Key Secondary Endpoints as LID Treatment

Common Gene Variation May Predict Parkinsonís Severity and Progression

Blood Test to Detect Parkinson's Disease Could Lead to Earlier Treatment

New England and Canada Parkinsonís Cruise

Cynapsus Therapeuticsí APL-130277 Phase III Study Focus of Presentation

Acorda Therapeuticsí CVT-301 Data Will Be Featured at American Academy of Neurology

Pfizer and IBM Launch Innovative Research Project to Transform Parkinson's Disease Care

The Parkinson Alliance (Responsible for the Parkinsonís Unity Walk, Team Parkinson, and DBS4PD.org) Joins Unified Parkinsonís Advocacy Council

U.S. WorldMeds and Zambon Partner to Bring Newron Pharmaceuticalsí Parkinsonís Disease Treatment Xadago to the U.S.

Titan Pharmaceuticals Receives Feedback from FDA on Ropinirole Implant Development Program for PD

Parkinsonís Disease Drug Xadago Now Available in Italy as Add-On Therapy to Levodopa

back to top